Develop innovative therapies to treat patients with rare or otherwise debilitating disease
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2021 | KNIGHT CAPITOL CONSULTANTS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2021 | KNIGHT CAPITOL CONSULTANTS |
2nd Quarter (Apr 1 - June 30) AMENDED |
— | |
| 2021 | KNIGHT CAPITOL CONSULTANTS |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| KNIGHT CAPITOL CONSULTANTS | 13 | — |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 12 |
| Health Issues | 11 |
| Taxation/Internal Revenue Code | 11 |
| Pharmacy | 11 |